Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Jake Vinson"'
Autor:
Rana R. McKay, Theresa Gold, Jelani C. Zarif, Ilkania M. Chowdhury-Paulino, Adam Friedant, Travis Gerke, Marie Grant, Kelly Hawthorne, Elisabeth Heath, Franklin W. Huang, Maria D. Jackson, Brandon Mahal, Osarenren Ogbeide, Kellie Paich, Camille Ragin, Emily M. Rencsok, Stacey Simmons, Clayton Yates, Jake Vinson, Philip W. Kantoff, Daniel J. George, Lorelei A. Mucci
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 495-505 (2021)
Prostate cancer disproportionately affects racial and ethnic minority populations. Reasons for disparate outcomes among minority patients are multifaceted and complex, involving factors at the patient, provider, and system levels. Although advancemen
Externí odkaz:
https://doaj.org/article/7de18708466145da944690de2001c913
Autor:
Daniel C. Danila, Daniel J. George, Celestia S. Higano, Charles J. Ryan, Veda N. Giri, Ana M. Molina, Zachery R. Reichert, Rana R. McKay, Julie N. Graff, Elisabeth I. Heath, Young E. Whang, Alicia K. Morgans, Emmanuel S. Antonarakis, Mary-Ellen Taplin, Akash Patnaik, Jake Vinson, Channing J. Paller, Matthew Rettig, Heather H. Cheng, Mallika Sachdev Dhawan, Tomasz M. Beer, Brittany M. Szymaniak, Maria I. Carlo, Glenn Liu, Lauren A. Facchini, Daniel P. Petrylak, Shilpa Gupta
Publikováno v:
JCO oncology practice, vol 16, iss 12
JCO Oncol Pract
JCO Oncol Pract
Germline genetic testing is now routinely recommended for patients with prostate cancer (PCa) because of expanded guidelines and options for targeted treatments. However, integrating genetic testing into oncology and urology clinical workflows remain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e9739fc663350096ea23710c714fb11
https://doi.org/10.1200/op.20.00431
https://doi.org/10.1200/op.20.00431
Autor:
Joaquin Mateo, Arul M. Chinnaiyan, William Oh, Maha Hussain, Nikolaus Schultz, Howard R. Soule, Eric J. Small, Rana R. McKay, Rahul Aggarwal, Wassim Abida, Fatima Karzai, David B. Solit, Eliezer M. Van Allen, Felix Y. Feng, Jake Vinson, Bruce Montgomery, Vaibhav G. Patel, Matthew R. Smith, David J. VanderWeele, Julie N. Graff, Himisha Beltran, William L. Dahut, Matthew Rettig, Dana E. Rathkopf, Andrea K. Miyahira, Ajjai Alva, Jonathan W. Simons, Cora N. Sternberg, Xin Gao, Joshi J. Alumkal
Publikováno v:
Nat Cancer
Nature cancer, vol 1, iss 11
Nature cancer, vol 1, iss 11
Despite advances in the screening and treatment of prostate cancer, the therapy options available, particularly for later stages of the disease, remain limited, and the treatment-resistant setting represents a serious unmet medical need. Moreover, di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fae1b9aacfdd2eeb9cd82061beac6aa0
https://doi.org/10.1038/s43018-020-00141-0
https://doi.org/10.1038/s43018-020-00141-0
Autor:
Anand Pathak, Anand Kolatkar, Amir Ali Talasaz, Julia A. Beaver, Daniel Edelstein, Matthew Ryder, Jerry S.H. Lee, Peter Kuhn, Lea M. Salvatore, Justin Johnson, Seema Singh Bhan, Allison Welsh, David A. Eberhard, James H Godsey, Howard I. Scher, Melanie Hullings, Carolyn Compton, James W. Hicks, Matthew Smalley, Robert L. Grossman, Jonathan W. Simons, Jake Vinson, Gideon M. Blumenthal, David Reese, Sean E. Hanlon, Walt Wells, Rebecca Levine, Phillip G. Febbo, Wendy Royalty, Lauren C. Leiman, Bryan Moy, Hsian-Rong Tseng, Ryan Dittamore, Daniel H. Hovelson, Daniel P. Miller, Anne-Marie Martin, Donald J Johann, Andrew E. Schade, J. Carl Barrett, Hakan Sakul, Carissa Moore, Stella Somiari, Kelli Bramlett, Paul J. Beresford, Andrew Gruen, Reena Philip, John K. Simmons, Angela Silvestro, Jean-Francois Martini, Muneesh Tewari
Publikováno v:
Clinical Pharmacology and Therapeutics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::021e87ff08b0cace4490eeb5f6d29110
http://europepmc.org/articles/PMC7158216
http://europepmc.org/articles/PMC7158216
Autor:
Nima Sharifi, Rana R. McKay, Jake Vinson, Mike A. Royal, Joshua Michael Lang, Eric A. Klein, Xiuxiu Li, Michael Berk, Christopher Goins, Mohammad Alyamani, Yoon-Mi Chung, Chenyao Wang, Mona Patel, Nityam Rathi, Ziqi Zhu, Belinda Willard, Shaun Stauffer
Publikováno v:
Journal of Clinical Oncology. 41:144-144
144 Background: Kinase inhibitors have been ineffective in prostate cancer and have no known role in androgen biosynthesis. Inheritance of the adrenal-permissive HSD3B1(1245C) allele encodes a 3βHSD1 enzyme missense that up-regulates the rate-limiti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d548401af91a59065ce15e8b22d1d92
https://doi.org/10.1200/jco.2023.41.6_suppl.144
https://doi.org/10.1200/jco.2023.41.6_suppl.144
Autor:
Lorelei A Mucci, Jake Vinson, Travis A. Gerke, Terry Hyslop, Lauren Howard, Robert Dreicer, Dana E. Rathkopf, Kim N. Chi, Emilio Esteban, Deborah Enting, Anders Bjartell, Scott T. Tagawa, David M. Nanus, Michael Ong, Pedro C. Barata, Sebastien J. Hotte, Marie Grant, Paul Villanti, Philip W. Kantoff, Daniel J. George
Publikováno v:
Journal of Clinical Oncology. 41:85-85
85 Background: Patients with advanced prostate cancer (APC) experience high mortality and increasingly deteriorating quality of life due to the disease itself and the therapies they are treated with. Despite recent advances in the treatment landscape
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dace24ed8dce2878101251425526f33a
https://doi.org/10.1200/jco.2023.41.6_suppl.85
https://doi.org/10.1200/jco.2023.41.6_suppl.85
Autor:
Stacey Simmons, Jake Vinson, Ilkania M. Chowdhury-Paulino, Jelani C. Zarif, Theresa Gold, Clayton Yates, Camille Ragin, Lorelei A. Mucci, Kelly Hawthorne, Philip W. Kantoff, Rana R. McKay, Kellie Paich, Emily M. Rencsok, Marie Grant, Franklin W. Huang, Daniel J. George, Maria D. Jackson, Travis Gerke, Osarenren Ogbeide, Adam Friedant, Elisabeth I. Heath, Brandon A. Mahal
Publikováno v:
JCO Global Oncology
Prostate cancer disproportionately affects racial and ethnic minority populations. Reasons for disparate outcomes among minority patients are multifaceted and complex, involving factors at the patient, provider, and system levels. Although advancemen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8337c5695b18e9f7db75f3048922385f
https://pubmed.ncbi.nlm.nih.gov/33835826
https://pubmed.ncbi.nlm.nih.gov/33835826
Autor:
Daniel J. George, Lorelei A Mucci, Philip W. Kantoff, Paul Villanti, Jake Vinson, Travis A. Gerke, Terry Hyslop, Emily Rencsok
Publikováno v:
Journal of Clinical Oncology. 40:TPS190-TPS190
TPS190 Background: Men with advanced prostate cancer (APC) experience high mortality and severely impacted quality of life due to the disease itself as well as its therapies, with Black men facing the highest disease burden. The treatment landscape f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17a865628542bf0c721abfd84a4c4df4
https://doi.org/10.1200/jco.2022.40.6_suppl.tps190
https://doi.org/10.1200/jco.2022.40.6_suppl.tps190
Autor:
Emily Rencsok, Daniel J. George, Philip W. Kantoff, Paul Villanti, Jake Vinson, Travis A. Gerke, Terry Hyslop, Lorelei A Mucci
Publikováno v:
Journal of Clinical Oncology. 40:69-69
69 Background: While population-based estimates of advanced prostate cancer survivors are lacking, an estimated 180,000 men in the US are living with metastatic prostate cancer. Their survivorship experience is distinct from localized patients as the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::100ca3ae080f3b460a70bb2515daa140
https://doi.org/10.1200/jco.2022.40.6_suppl.069
https://doi.org/10.1200/jco.2022.40.6_suppl.069
Autor:
Channing Judith Paller, Justin Lorentz, Tiffani DeMarco, Walter Michael Stadler, Andrew J. Armstrong, Mary-Ellen Taplin, Maha H. A. Hussain, Roberto Pili, Shifeng S. Mao, Jo Ann Elrod, Alexandra Sokolova, Elisabeth I. Heath, Rana R. McKay, Jake Vinson, Rebecca Green, Christina Tran, Natalie Macario, Audrey Cook, Jenny Chiang, Heather H. Cheng
Publikováno v:
Journal of Clinical Oncology. 40:TPS191-TPS191
TPS191 Background: Recent updates to genetic testing recommendations and approved treatment options for prostate cancer (PCa) patients (pts) have clarified the need for comprehensive genetic registries. Germline DNA damage repair (DDR) defects are pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1901b8a1bd95a33b7973bc061fada172
https://doi.org/10.1200/jco.2022.40.6_suppl.tps191
https://doi.org/10.1200/jco.2022.40.6_suppl.tps191